Stay updated with breaking news from Nasdaq Adap. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) CEO Adrian Rawcliffe sold 11,945 shares of the firm’s stock in a transaction on Thursday, January 11th. The stock was sold at an average price of $0.84, for a total transaction of $10,033.80. Following the transaction, the chief executive officer now directly owns 18,395 shares of the […]
Marquette Asset Management LLC purchased a new position in Adaptimmune Therapeutics plc (NASDAQ:ADAP – Free Report) in the third quarter, Holdings Channel reports. The fund purchased 99,349 shares of the biotechnology company’s stock, valued at approximately $77,000. Other large investors also recently bought and sold shares of the company. Two Sigma Investments LP acquired a […]
StockNews.com initiated coverage on shares of Adaptimmune Therapeutics (NASDAQ:ADAP – Free Report) in a research report sent to investors on Friday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Adaptimmune Therapeutics Trading Up 14.9 % Shares of NASDAQ:ADAP opened at $0.79 on Friday. Adaptimmune Therapeutics has a 1 year low of […]
StockNews.com started coverage on shares of Adaptimmune Therapeutics (NASDAQ:ADAP – Free Report) in a report issued on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. Adaptimmune Therapeutics Stock Up 14.9 % NASDAQ:ADAP opened at $0.79 on Friday. The stock has a market capitalization of $788.41 million, a price-to-earnings ratio of […]
StockNews.com initiated coverage on shares of Adaptimmune Therapeutics (NASDAQ:ADAP – Free Report) in a research report sent to investors on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. Adaptimmune Therapeutics Price Performance Shares of ADAP opened at $0.79 on Friday. The firm has a 50-day simple moving average of $0.53 and […]